CommercialAdministrativeLow impact
08.00.49f, Dofetilide (Tikosyn®) Use in the Inpatient Setting
Independence Blue Cross·Cardiology, Critical Care·Pharmacy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
The Dofetilide (Tikosyn®) inpatient use policy has been reissued effective April 1, 2026. This is a reissue of existing policy rather than substantive changes to coverage or billing requirements for this cardiac medication used in hospital settings.
Action Required
By April 1, 2026: Billing team should review the reissued Dofetilide (Tikosyn®) inpatient policy to ensure compliance with any updated language or formatting changes, though no immediate billing changes are indicated.